Amgen Inc.
AFLIBERCEPT ATTRIBUTES AND METHODS OF CHARACTERIZING AND MODIFYING THEREOF
Last updated:
Abstract:
The present disclosure relates to aflibercept, in particular, attributes of aflibercept. Also provided herein are methods of characterizing and modifying the attributes of aflibercept and compositions comprising aflibercept with particular attributes.
Status:
Application
Type:
Utility
Filling date:
29 Jan 2020
Issue date:
31 Mar 2022